Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 294 articles: HTML format

Single Articles

July 2021
1. MCFARLANE MR, Hochstedler KA, Laucis AM, Sun Y, et al
   Predictors of Pneumonitis after Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2021 Jul 24. pii: S0360-3016(21)02561.
   PubMed     Abstract available
   
   
   
2. XU T, Meng QH, Gilchrist SC, Lin SH, et al
   Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiotherapy-Induced Cardiotoxicity in Non-Small Cell Lung Cancer Patients: A Secondary Analysis of a Prospective Randomized Trial.
   Int J Radiat Oncol Biol Phys. 2021 Jul 21. pii: S0360-3016(21)00905.
   PubMed     Abstract available
   
   
   
3. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
   COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
   Int J Radiat Oncol Biol Phys. 2021;110:957-961.
   PubMed     Abstract available
   
   
   
4. QIU B, Wang D, Li Q, Wu Y, et al
   Concurrent chemoradiotherapy with or without nimotuzumab in locally advanced squamous cell lung cancer: a phase 2 randomized trial.
   Int J Radiat Oncol Biol Phys. 2021 Jul 3. pii: S0360-3016(21)00824.
   PubMed     Abstract available
   
   
   June 2021
5. TSAO MN, Louie AV
   Radical Radiation for Large-Volume Locally Advanced Non-Small Cell Lung Cancer: Constrained by Constraints!
   Int J Radiat Oncol Biol Phys. 2021;110:261-263.
   PubMed    
   
   
   May 2021
6. YU F, Ni J, Zeng W, Zhou Y, et al
   Clinical value of upfront cranial radiotherapy in osimertinib-treated EGFR-mutant non-small-cell lung cancer with brain metastases.
   Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00667.
   PubMed     Abstract available
   
   
   
7. VIDETIC GMM, Reddy CA, Woody NM, Stephans KL, et al
   Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00658.
   PubMed     Abstract available
   
   
   
8. QIU B, Li Q, Liu J, Huang Y, et al
   Moderately Hypofractionated Once-daily Compared with Twice-daily Thoracic Radiotherapy Concurrently with Etoposide and Cisplatin in Limited-stage Small-cell Lung Cancer: a Multi-center, Phase II, Randomized Trial.
   Int J Radiat Oncol Biol Phys. 2021 May 13. pii: S0360-3016(21)00490.
   PubMed     Abstract available
   
   
   
9. KIM H, Keller A, Beriwal S, Smith KJ, et al
   Cost-Effectiveness of Prophylactic Cranial Irradiation versus MRI Surveillance for Extensive Stage Small Cell Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2021 May 10. pii: S0360-3016(21)00477.
   PubMed     Abstract available
   
   
   April 2021
10. STEBER CR, Hughes RT, Urbanic J, Clark H, et al
    Long-Term Outcomes from a Phase 2 Trial of Radiofrequency Ablation Combined with External Beam Radiation Therapy for Patients with Inoperable Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 28. pii: S0360-3016(21)00402.
    PubMed     Abstract available
    
    
    
11. SHURYAK I, Kachnic LA, Brenner DJ
    Lung Cancer and Heart Disease Risks Associated with Low-Dose Pulmonary Radiotherapy to COVID-19 Patients with Different Background Risks.
    Int J Radiat Oncol Biol Phys. 2021 Apr 27. pii: S0360-3016(21)00379.
    PubMed     Abstract available
    
    
    
12. MALDONADO F, Gonzalez-Ling A, Onate-Ocana LF, Cabrera-Miranda LA, et al
    Prophylactic Cranial Irradiation in high-risk metastatic non-small cell lung cancer patients: Quality of life and neurocognitive analysis of a randomized phase II study.
    Int J Radiat Oncol Biol Phys. 2021 Apr 26. pii: S0360-3016(21)00378.
    PubMed     Abstract available
    
    
    
13. TATEISHI Y, Takeda A, Horita N, Tsurugai Y, et al
    Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 20. pii: S0360-3016(21)00375.
    PubMed     Abstract available
    
    
    
14. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available
    
    
    
15. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed     Abstract available
    
    
    
16. TROVO M, Relevant A, Polesel J, Muraro E, et al
    Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1368-1376.
    PubMed     Abstract available
    
    
    
17. HASLETT K, Bayman N, Franks K, Groom N, et al
    Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1341-1348.
    PubMed     Abstract available
    
    
    
18. THOR M, Apte A, Haq R, Iyer A, et al
    Using Auto-Segmentation to Reduce Contouring and Dose Inconsistency in Clinical Trials: The Simulated Impact on RTOG 0617.
    Int J Radiat Oncol Biol Phys. 2021;109:1619-1626.
    PubMed     Abstract available
    
    
    
19. PAN T, Lu Y, Thomas MA, Liao Z, et al
    New Data-Driven Gated PET/CT Free of Misregistration Artifacts.
    Int J Radiat Oncol Biol Phys. 2021;109:1638-1646.
    PubMed     Abstract available
    
    
    March 2021
20. HOSKIN P
    Double the Target Volumes.
    Int J Radiat Oncol Biol Phys. 2021;109:846.
    PubMed    
    
    
    
21. ATKINS KM, Bitterman DS, Chaunzwa TL, Kozono DE, et al
    Mean Heart Dose is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00245.
    PubMed     Abstract available
    
    
    
22. LEE SH, Kao GD, Feigenberg SJ, Dorsey JF, et al
    Multi-block Discriminant Analysis of Integrative (18)F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 1. pii: S0360-3016(21)00208.
    PubMed     Abstract available
    
    
    
23. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available
    
    
    February 2021
24. ARRIETA O, Maldonado F, Turcott JG, Zatarain-Barron ZL, et al
    Prophylactic Cranial Irradiation reduces brain metastases and improves overall survival in high-risk metastatic non-small cell lung cancer patients: a randomized phase II study (PRoT-BM trial).
    Int J Radiat Oncol Biol Phys. 2021 Feb 25. pii: S0360-3016(21)00225.
    PubMed     Abstract available
    
    
    
25. YU JH, Zhao QY, Liu Y, Zhu XR, et al
    The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021 Feb 17. pii: S0360-3016(21)00070.
    PubMed     Abstract available
    
    
    
26. CUI S, Ten Haken RK, El Naqa I
    Integrating multi-omics information in deep learning architectures for joint actuarial outcome prediction in non-small-cell lung cancer patients after radiation therapy.
    Int J Radiat Oncol Biol Phys. 2021 Feb 1. pii: S0360-3016(21)00116.
    PubMed     Abstract available
    
    
    
27. DUNNE EM, Liu M
    Postoperative Stereotactic Body Radiation Therapy, Then Observe.
    Int J Radiat Oncol Biol Phys. 2021;109:316.
    PubMed    
    
    
    
28. DE BARI B
    Cautious SBRT.
    Int J Radiat Oncol Biol Phys. 2021;109:315.
    PubMed    
    
    
    
29. HELM A, Tinganelli W, Simoniello P, Kurosawa F, et al
    Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
    Int J Radiat Oncol Biol Phys. 2021;109:594-602.
    PubMed     Abstract available
    
    
    
30. NAM JK, Kim AR, Choi SH, Kim JH, et al
    Pharmacologic Inhibition of HIF-1alpha Attenuates Radiation-Induced Pulmonary Fibrosis in a Preclinical Image Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:553-566.
    PubMed     Abstract available
    
    
    January 2021
31. SALAMA JK, Giuliani ME, Robinson CG, Daly ME, et al
    Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?
    Int J Radiat Oncol Biol Phys. 2021;109:1-4.
    PubMed    
    
    
    
32. NGUYEN C, Dietz N
    Lung Mass With Massive Hemoptysis: Treatment Without Tissue Diagnosis.
    Int J Radiat Oncol Biol Phys. 2021;109:5-6.
    PubMed    
    
    
    December 2020
33. JIAO Z, Li H, Xiao Y, Aggarwal C, et al
    Integration of risk survival measures estimated from pre- and post-treatment CT scans improves stratification of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34660.
    PubMed     Abstract available
    
    
    
34. HIGGINS KA, Curran WJ Jr, Liu SV, Yu W, et al
    Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC).
    Int J Radiat Oncol Biol Phys. 2020;108:1398.
    PubMed    
    
    
    
35. DETAPPE A, Mathieu C, Jin C, Agius MP, et al
    Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1380-1389.
    PubMed     Abstract available
    
    
    November 2020
36. IWATA H, Akita K, Yamaba Y, Kunii E, et al
    Concurrent Chemo-proton Therapy Using Adaptive Planning for Unresectable Stage III Non-small Cell Lung Cancer: A Phase II Study.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34557.
    PubMed     Abstract available
    
    
    
37. XING L, Wu G, Wang L, Li J, et al
    Erlotinib vs etoposide/cisplatin with radiotherapy in unresectable stage III epidermal growth factor receptor mutation-positive non-small-cell lung cancer: A multicenter, randomized, open-label, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2020 Nov 18. pii: S0360-3016(20)34548.
    PubMed     Abstract available
    
    
    
38. VASQUEZ OSORIO EM, McCallum H, Bedair A, Faivre-Finn C, et al
    Protecting the Heart: A Practical Approach to Account for the Full Extent of Heart Motion in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:1082-1090.
    PubMed     Abstract available
    
    
    
39. MCWILLIAM A, Khalifa J, Vasquez Osorio E, Banfill K, et al
    Novel Methodology to Investigate the Effect of Radiation Dose to Heart Substructures on Overall Survival.
    Int J Radiat Oncol Biol Phys. 2020;108:1073-1081.
    PubMed     Abstract available
    
    
    
40. KIM YE, Gwak SH, Hong BJ, Oh JM, et al
    Effects of ultra-high dose rate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain.
    Int J Radiat Oncol Biol Phys. 2020 Nov 10. pii: S0360-3016(20)34500.
    PubMed     Abstract available
    
    
    
41. GUTIONTOV SI, Pitroda SP, Weichselbaum RR
    Oligometastasis: Past, Present, Future.
    Int J Radiat Oncol Biol Phys. 2020;108:530-538.
    PubMed     Abstract available
    
    
    
42. TOMA-DASU I, Moiseenko V, Purdie TG, Carlson DJ, et al
    Recent Developments in the Prediction of Clinical Outcomes Data in Radiation Oncology.
    Int J Radiat Oncol Biol Phys. 2020;108:513-517.
    PubMed    
    
    
    
43. MIRSCH J, Hintz L, Maier A, Fournier C, et al
    An Assessment of Radiation Doses From Radon Exposures Using a Mouse Model System.
    Int J Radiat Oncol Biol Phys. 2020;108:770-778.
    PubMed     Abstract available
    
    
    October 2020
44. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed     Abstract available
    
    
    September 2020
45. PEREZ BA, Kim S, Wang M, Karimi AM, et al
    A Prospective Single Arm Phase I/II Study: Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Sep 28. pii: S0360-3016(20)34303.
    PubMed     Abstract available
    
    
    
46. YIN L, Xue J, Li R, Zhou L, et al
    Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:212-224.
    PubMed     Abstract available
    
    
    
47. TIAN S, Switchenko JM, Buchwald ZS, Patel PR, et al
    Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2020;108:304-313.
    PubMed     Abstract available
    
    
    July 2020
48. GUCKENBERGER M, Belka C, Bezjak A, Bradley J, et al
    Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.
    Int J Radiat Oncol Biol Phys. 2020;107:631-640.
    PubMed     Abstract available
    
    
    
49. NENOFF L, Matter M, Jarhall AG, Winterhalter C, et al
    Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption?
    Int J Radiat Oncol Biol Phys. 2020;107:747-755.
    PubMed     Abstract available
    
    
    June 2020
50. ZAYED S, Chen H, Ali E, Rodrigues GB, et al
    Is there a Role for Hypofractionated Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31249.
    PubMed     Abstract available
    
    
    
51. PAUL S, Bodner WR, Garg M, Tang J, et al
    Cardiac Irradiation Predicts Activity Decline in Patients Receiving Concurrent Chemoradiation for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 1. pii: S0360-3016(20)31208.
    PubMed     Abstract available
    
    
    
52. FINAZZI T, Haasbeek CJA, Spoelstra FOB, Palacios MA, et al
    Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2020;107:270-278.
    PubMed     Abstract available
    
    
    
53. AYOUB Z, Ning MS, Brooks ED, Kang J, et al
    Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:261-269.
    PubMed     Abstract available
    
    
    May 2020
54. WANG W, Matuszak MM, Hu C, Huang KC, et al
    Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 May 26. pii: S0360-3016(20)31150.
    PubMed     Abstract available
    
    
    
55. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.
    PubMed    
    
    
    
56. ZENG Y, Liu Q, Wang Y, Tian C, et al
    CDK5 activates Hippo signaling to confer resistance to radiotherapy via upregulating TAZ in lung cancer.
    Int J Radiat Oncol Biol Phys. 2020 May 11. pii: S0360-3016(20)31129.
    PubMed     Abstract available
    
    
    
57. GUO T, Ni J, Yang X, Li Y, et al
    Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:62-71.
    PubMed     Abstract available
    
    
    April 2020
58. HULSBERGEN AFC, Mammi M, Nagtegaal SHJ, Lak AM, et al
    Programmed death receptor ligand one expression may independently predict survival in non-small cell lung carcinoma brain metastases patients receiving immunotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Apr 23. pii: S0360-3016(20)31036.
    PubMed     Abstract available
    
    
    
59. KONG C, Zhu X, Shi M, Wang L, et al
    Survival and Toxicity of Hypofractionated Intensity-Modulated Radiotherapy in 4-Gy Fractions for Unresectable Stage III Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Apr 7. pii: S0360-3016(20)30979.
    PubMed     Abstract available
    
    
    
60. HOPPE BS, Nichols RC, Flampouri S, Li Z, et al
    Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A Phase I trial from the University of Florida and Proton Collaborative Group.
    Int J Radiat Oncol Biol Phys. 2020 Apr 3. pii: S0360-3016(20)30938.
    PubMed     Abstract available
    
    
    March 2020
61. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    PubMed     Abstract available
    
    
    
62. KIM MM, Parmar HA, Schipper M, Devasia T, et al
    BRAINSTORM: A Multi-Institutional Phase I/II Study of RRx-001 in Combination with Whole Brain Radiation Therapy for Patients with Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Mar 10. pii: S0360-3016(20)30890.
    PubMed     Abstract available
    
    
    
63. VEES H, Caparrotti F, Eboulet EI, Xyrafas A, et al
    IMPACT OF EARLY PROPHYLACTIC CRANIAL IRRADIATION WITH HIPPOCAMPAL AVOIDANCE ON NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LIMITED DISEASE SMALL-CELL LUNG CANCER. A MULTICENTER PHASE II TRIAL (SAKK 15/12).
    Int J Radiat Oncol Biol Phys. 2020 Mar 3. pii: S0360-3016(20)30255.
    PubMed     Abstract available
    
    
    
64. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed    
    
    
    
65. HAGAN M, Kapoor R, Michalski J, Sandler H, et al
    VA-Radiation Oncology Quality Surveillance Program.
    Int J Radiat Oncol Biol Phys. 2020;106:639-647.
    PubMed     Abstract available
    
    
    
66. VAN MARLEN P, Dahele M, Folkerts M, Abel E, et al
    Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
    Int J Radiat Oncol Biol Phys. 2020;106:621-629.
    PubMed     Abstract available
    
    
    
67. KAMRAVA M, Chino JP, Beriwal S
    SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Int J Radiat Oncol Biol Phys. 2020;106:472-474.
    PubMed    
    
    
    February 2020
68. SALEEM A, Helo Y, Win Z, Dale R, et al
    Integrin alphavbeta6 positron emission tomography imaging in lung cancer patients treated with pulmonary radiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Feb 11. pii: S0360-3016(20)30184.
    PubMed     Abstract available
    
    
    
69. CORNELL M, Kaderka R, Hild SJ, Ray XJ, et al
    Noninferiority Study of Automated Knowledge-Based Planning Versus Human-Driven Optimization Across Multiple Disease Sites.
    Int J Radiat Oncol Biol Phys. 2020;106:430-439.
    PubMed     Abstract available
    
    
    
70. TANG C, Lee WC, Reuben A, Chang L, et al
    Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2020;106:349-357.
    PubMed     Abstract available
    
    
    
71. TRIFILETTI DM, Ballman KV, Brown PD, Anderson SK, et al
    Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
    Int J Radiat Oncol Biol Phys. 2020;106:255-260.
    PubMed     Abstract available
    
    
    
72. GREWAL AS, Min EJ, Long Q, Grewal SK, et al
    Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2020;106:358-368.
    PubMed     Abstract available
    
    
    January 2020
73. PENG J, Pond G, Donovan E, Ellis PM, et al
    A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(19)34545.
    PubMed     Abstract available
    
    
    
74. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
    To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
    PubMed     Abstract available
    
    
    
75. O'REILLY S, Jain V, Huang Q, Cheng C, et al
    Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30073.
    PubMed     Abstract available
    
    
    
76. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    PubMed     Abstract available
    
    
    
77. VINOGRADSKIY Y, Diot Q, Jones B, Castillo R, et al
    Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 23. pii: S0360-3016(19)34526.
    PubMed     Abstract available
    
    
    
78. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia.
    Int J Radiat Oncol Biol Phys. 2020;106:61-66.
    PubMed     Abstract available
    
    
    
79. DUIJM M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, et al
    Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Int J Radiat Oncol Biol Phys. 2020;106:73-81.
    PubMed     Abstract available
    
    
    
80. LI R, Shinde A, Novak J, Vapiwala N, et al
    Temporal Trends of Resident Experience in External Beam Radiation Therapy Cases: Analysis of ACGME Case Logs from 2007 to 2018.
    Int J Radiat Oncol Biol Phys. 2020;106:37-42.
    PubMed     Abstract available
    
    
    December 2019
81. FENWICK JD, Landau DB, Baker A, Bates AT, et al
    Long-term results from the IDEAL-CRT phase 1/2 trial of isotoxically dose-escalated radiation therapy and concurrent chemotherapy for stage II/III non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2019 Dec 3. pii: S0360-3016(19)34456.
    PubMed     Abstract available
    
    
    November 2019
82. QIN A, Rengan R, Lee S, Santana-Davila R, et al
    A Pilot Study of Atezolizumab plus Hypofractionated Image-guided Radiotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 19. pii: S0360-3016(19)34007.
    PubMed     Abstract available
    
    
    October 2019
83. WANG XS, Shi Q, Mendoza T, Lin S, et al
    Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-small Cell Lung Cancer: A Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019 Oct 15. pii: S0360-3016(19)33883.
    PubMed     Abstract available
    
    
    
84. KANG J, Ning MS, Feng H, Li H, et al
    Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.
    Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33861.
    PubMed     Abstract available
    
    
    September 2019
85. OHNISHI K, Nakamura N, Harada H, Tokumaru S, et al
    Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Int J Radiat Oncol Biol Phys. 2019 Sep 30. pii: S0360-3016(19)33837.
    PubMed     Abstract available
    
    
    
86. OZSAHIN M, Slotman BJ, Bourhis J
    Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;105:233-234.
    PubMed    
    
    
    
87. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed    
    
    
    
88. HOPPE RT
    20 Gy Versus 30 Gy: Will it Make a Difference?
    Int J Radiat Oncol Biol Phys. 2019;105:102-103.
    PubMed    
    
    
    August 2019
89. CHO Y, Park S, Byun HK, Lee CG, et al
    Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Aug 30. pii: S0360-3016(19)33733.
    PubMed     Abstract available
    
    
    
90. SINGH AK, Gomez-Suescun JA, Stephans KL, Bogart JA, et al
    One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2019 Aug 22. pii: S0360-3016(19)33653.
    PubMed     Abstract available
    
    
    
91. LIU C, Sun B, Hu X, Zhang Y, et al
    Stereotactic ablative radiotherapy for pulmonary recurrence-based oligometastatic non-small cell lung cancer: survival and prognostic value of regulatory T cells.
    Int J Radiat Oncol Biol Phys. 2019 Aug 19. pii: S0360-3016(19)33646.
    PubMed     Abstract available
    
    
    
92. DING X, Cheng J, Pang Q, Wei X, et al
    BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33642.
    PubMed     Abstract available
    
    
    
93. OHRI N, Halmos B, Bodner WR, Cheng H, et al
    Daily step counts: A new prognostic factor in locally advanced non-small cell lung cancer?
    Int J Radiat Oncol Biol Phys. 2019 Aug 6. pii: S0360-3016(19)33560.
    PubMed     Abstract available
    
    
    
94. PALMA D, Zhang T
    In Reply to Banfill et al.
    Int J Radiat Oncol Biol Phys. 2019;104:1180.
    PubMed    
    
    
    
95. BANFILL KE, McWilliam A, van Herk M, Faivre-Finn C, et al
    In Regard to Zhang et al.
    Int J Radiat Oncol Biol Phys. 2019;104:1179-1180.
    PubMed    
    
    
    
96. BILLFALK-KELLY A, Yu E, Su J, O'Sullivan B, et al
    Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:1017-1027.
    PubMed     Abstract available
    
    
    July 2019
97. LIN SH
    The Role of Adjuvant Radiotherapy for Resected Non-Small Cell Lung Cancer in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2019;104:712-713.
    PubMed    
    
    
    
98. NIAZI MZ, Golden DW
    Thoracic Postoperative Radiation Therapy: To Treat or Not to Treat?
    Int J Radiat Oncol Biol Phys. 2019;104:710.
    PubMed    
    
    
    
99. FINAZZI T, Palacios MA, Spoelstra FOB, Haasbeek CJA, et al
    Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2019;104:933-941.
    PubMed     Abstract available
    
    
    
100. BADIYAN SN, Robinson CG, Bradley JD
     Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?
     Int J Radiat Oncol Biol Phys. 2019;104:590-592.
     PubMed    
     
     
     
101. SAMPATH S, Rahmanuddin S, Sahoo P, Frankel P, et al
     Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial.
     Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33424.
     PubMed     Abstract available
     
     
     
102. MENZEL P, Theodosopoulos P
     A Caudate Conundrum.
     Int J Radiat Oncol Biol Phys. 2019;104:481-482.
     PubMed    
     
     
     June 2019
103. XIE L, Bao X, Cai T, Silva SG, et al
     Elevated risk of radiotherapy-associated second malignant neoplasms in young African American women survivors of stage I-IIIA breast cancer.
     Int J Radiat Oncol Biol Phys. 2019 Jun 12. pii: S0360-3016(19)30835.
     PubMed     Abstract available
     
     
     
104. LADBURY CJ, Rusthoven CG, Camidge DR, Kavanagh BD, et al
     Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2019 Jun 5. pii: S0360-3016(19)30818.
     PubMed     Abstract available
     
     
     
105. VIDETIC GM
     In Reply to Yilmaz et al.
     Int J Radiat Oncol Biol Phys. 2019;104:467.
     PubMed    
     
     
     
106. YILMAZ MT, Hurmuz P, Cengiz M
     In Regard to Videtic et al.
     Int J Radiat Oncol Biol Phys. 2019;104:466-467.
     PubMed    
     
     
     
107. LAVIGNE J, Suissa A, Verger N, Dos Santos M, et al
     Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1alpha Endothelial Deletion.
     Int J Radiat Oncol Biol Phys. 2019;104:279-290.
     PubMed     Abstract available
     
     
     May 2019
108. FRANCESCHINI D, De Rose F, Franzese C, Comito T, et al
     Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2019;104:111-121.
     PubMed     Abstract available
     
     
     April 2019
109. SIVA S, Ball DL
     Single Fraction SBRT for Early Stage Lung Cancer-Less is More?
     Int J Radiat Oncol Biol Phys. 2019;103:1085-1087.
     PubMed    
     
     
     
110. RUSTHOVEN CG
     Small Cell Lung Cancer: PCI Uncertainty and Emerging Radiosurgery Interest.
     Int J Radiat Oncol Biol Phys. 2019;103:1034-1035.
     PubMed    
     
     
     
111. SHINDE A, Amini A
     Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2019;103:1031-1032.
     PubMed    
     
     
     
112. GASPAR LE
     A Gray Zone Regarding Gray Matter.
     Int J Radiat Oncol Biol Phys. 2019;103:1033-1034.
     PubMed    
     
     
     
113. WEGNER RE, Hasan S
     Observe the Brain and Preserve the Mind.
     Int J Radiat Oncol Biol Phys. 2019;103:1033.
     PubMed    
     
     
     
114. LARSEN F, Terlizzi M, Linacre V, Sargos P, et al
     Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study.
     Int J Radiat Oncol Biol Phys. 2019;103:1175-1181.
     PubMed     Abstract available
     
     
     March 2019
115. PALMA D, Daly M, Urbanic J, Giuliani M, et al
     Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
     Int J Radiat Oncol Biol Phys. 2019;103:788-791.
     PubMed    
     
     
     
116. MA JT, Liu Y, Sun L, Milano MT, et al
     Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
     Int J Radiat Oncol Biol Phys. 2019;103:843-850.
     PubMed     Abstract available
     
     
     
117. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
     Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
     PubMed     Abstract available
     
     
     February 2019
118. PALMA G, Monti S, Xu T, Scifoni E, et al
     Spatial Dose Patterns Associated with Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Radiation Therapy with Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2019 Feb 26. pii: S0360-3016(19)30274.
     PubMed     Abstract available
     
     
     
119. TUCKER SL, Xu T, Paganetti H, Deist T, et al
     Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
     Int J Radiat Oncol Biol Phys. 2019;103:403-410.
     PubMed     Abstract available
     
     
     January 2019
120. BERLIN E, Buckstein M, Yip R, Yankelevitz DF, et al
     Definitive Radiation for Stage I lung cancer in a screened population: Results from the I-ELCAP.
     Int J Radiat Oncol Biol Phys. 2019 Jan 21. pii: S0360-3016(19)30110.
     PubMed     Abstract available
     
     
     
121. ZHANG TW, Snir J, Boldt RG, Rodrigues GB, et al
     Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature.
     Int J Radiat Oncol Biol Phys. 2019 Jan 7. pii: S0360-3016(18)34226.
     PubMed     Abstract available
     
     
     
122. 
     Erratum to: Kasmann L, Manapov F. Immune Checkpoint Inhibition Combined With Intracranial Stereotactic Radiation Therapy in Non-Small Cell Lung Cancer: Is There an Increased Rate of Radionecrosis or Not? Int J Radiat Oncol Biol Phys 2018;102:465.
     Int J Radiat Oncol Biol Phys. 2019;103:286.
     PubMed    
     
     
     
123. SAHGAL A
     Lead with Surgery, SBRT to Follow.
     Int J Radiat Oncol Biol Phys. 2019;103:16-17.
     PubMed    
     
     
     
124. STAM B, Kwint M, Guckenberger M, Mantel F, et al
     Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.
     Int J Radiat Oncol Biol Phys. 2019;103:132-141.
     PubMed     Abstract available
     
     
     
125. KALAPURAKAL JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, et al
     Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.
     Int J Radiat Oncol Biol Phys. 2019;103:28-37.
     PubMed     Abstract available
     
     
     
126. HOF SV, Delaney AR, Tekatli H, Twisk J, et al
     Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm.
     Int J Radiat Oncol Biol Phys. 2019;103:259-267.
     PubMed     Abstract available
     
     
     December 2018
127. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
     Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
     PubMed     Abstract available
     
     
     November 2018
128. YILMAZ U, Wong TZ, Marks LB
     How Good Is Positron Emission Tomography at Detecting Previously-Occult Metastatic Lung Cancer at Diagnosis?
     Int J Radiat Oncol Biol Phys. 2018;102:716-717.
     PubMed    
     
     
     
129. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
     Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
     Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
     PubMed     Abstract available
     
     
     
130. SIO TT, Atherton PJ, Pederson LD, Zhen WK, et al
     Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.
     Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33924.
     PubMed     Abstract available
     
     
     
131. YAMAMOTO M, Aiyama H, Koiso T, Watanabe S, et al
     Validity of a Recently-Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Brain Metastasis Patients Undergoing Multiple Radiosurgical Procedures.
     Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33925.
     PubMed     Abstract available
     
     
     
132. FRICK MA, Kao GD, Aguarin L, Chinniah C, et al
     Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.
     Int J Radiat Oncol Biol Phys. 2018;102:536-542.
     PubMed     Abstract available
     
     
     October 2018
133. PINDER-ARABPOUR A, Jones B, Castillo R, Castillo E, et al
     Characterizing Spatial Lung Function For Esophageal Cancer Patients Undergoing Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33913.
     PubMed     Abstract available
     
     
     
134. YIN X, Mason J, Lobachevsky PN, Munforte L, et al
     Radiotherapy Modulates DNA Repair Efficiency in Peripheral Blood Mononuclear Cells Of Patients With Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Oct 9. pii: S0360-3016(18)33833.
     PubMed     Abstract available
     
     
     
135. FERRIS MJ, Jiang R, Behera M, Ramalingam SS, et al
     Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;102:383-390.
     PubMed     Abstract available
     
     
     
136. VANDERSTRAETEN B, Goddeeris B, Vandecasteele K, van Eijkeren M, et al
     Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical Preference.
     Int J Radiat Oncol Biol Phys. 2018;102:443-450.
     PubMed     Abstract available
     
     
     September 2018
137. JIN P, Machiels M, Crama KF, Visser J, et al
     Dosimetric benefits of mid-position compared with internal target volume strategy for esophageal cancer radiation therapy.
     Int J Radiat Oncol Biol Phys. 2018 Sep 22. pii: S0360-3016(18)33804.
     PubMed     Abstract available
     
     
     
138. KELADA OJ, Decker RH, Nath SK, Johung KL, et al
     High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
     Int J Radiat Oncol Biol Phys. 2018;102:174-183.
     PubMed     Abstract available
     
     
     August 2018
139. YANG P, Xu T, Gomez DR, Deng W, et al
     Patterns of Local-Regional Failure after Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy with Concurrent Chemotherapy for Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Aug 27. pii: S0360-3016(18)33637.
     PubMed     Abstract available
     
     
     
140. PAZ A, Yamamoto N, Sakama M, Matsufuji N, et al
     Tumor control probability analysis for single fraction carbon ion radiotherapy of early-stage non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2018 Aug 1. pii: S0360-3016(18)33466.
     PubMed     Abstract available
     
     
     July 2018
141. DIELEMAN EMT, Uitterhoeve ALJ, van Hoek MW, van Os RM, et al
     Concurrent daily Cisplatin and high dose radiotherapy in patients with stage III non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2018 Jul 25. pii: S0360-3016(18)31641.
     PubMed     Abstract available
     
     
     
142. BRADE AM, Wenz F, Koppe F, Lievens Y, et al
     Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
     Int J Radiat Oncol Biol Phys. 2018;101:927-934.
     PubMed     Abstract available
     
     
     
143. BOONYAWAN K, Gomez DR, Komaki R, Xu Y, et al
     Clinical and Dosimetric Factors Predicting Grade >/=2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
     Int J Radiat Oncol Biol Phys. 2018;101:919-926.
     PubMed     Abstract available
     
     
     
144. TORRE-BOUSCOULET L, Arroyo-Hernandez M, Martinez-Briseno D, Munoz-Montano WR, et al
     Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2018;101:910-918.
     PubMed     Abstract available
     
     
     
145. PETTY WJ, Urbanic JJ, Ahmed T, Hughes R, et al
     Long Term Outcomes of a Phase II Trial of Chemotherapy with Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Jul 9. pii: S0360-3016(18)31401.
     PubMed     Abstract available
     
     
     
146. HURMUZ P, Ozyigit G
     In Regard to Nantavithya et al.
     Int J Radiat Oncol Biol Phys. 2018;101:744-745.
     PubMed    
     
     
     
147. GROSSHANS DR, Brown PD
     Chemotherapy Plus Proton or Photon Radiation on a Trial.
     Int J Radiat Oncol Biol Phys. 2018;101:518-519.
     PubMed    
     
     
     June 2018
148. ZHANG P, Yorke E, Mageras G, Rimner A, et al
     Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Jun 2. pii: S0360-3016(18)30908.
     PubMed     Abstract available
     
     
     
149. JOHNSON CN, Price GJ, Faivre-Finn C, Aznar MC, et al
     Residual setup errors towards the heart after image guidance linked with poorer survival in lung cancer patients: do we need stricter IGRT protocols?
     Int J Radiat Oncol Biol Phys. 2018 Jun 1. pii: S0360-3016(18)30904.
     PubMed     Abstract available
     
     
     May 2018
150. YAMAMOTO T, Kabus S, Bal M, Bzdusek K, et al
     Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 May 4. pii: S0360-3016(18)30741.
     PubMed     Abstract available
     
     
     
151. LOUIE AV
     A Small Window of Opportunity When Disease Is Limited in Extensive-Stage Small Cell Lung Cancer?
     Int J Radiat Oncol Biol Phys. 2018;101:7.
     PubMed    
     
     
     
152. GORE EM
     Select Patients With "Limited" Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively.
     Int J Radiat Oncol Biol Phys. 2018;101:6-7.
     PubMed    
     
     
     
153. WANG HH, Wu ZQ, Qian D, Zaorsky NG, et al
     Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.
     Int J Radiat Oncol Biol Phys. 2018;101:49-62.
     PubMed     Abstract available
     
     
     
154. CHEN H, Laba JM, Boldt RG, Goodman CD, et al
     Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
     Int J Radiat Oncol Biol Phys. 2018;101:186-194.
     PubMed     Abstract available
     
     
     
155. BANG A, Kendal WS, Laurie SA, Cook G, et al
     Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
     Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30736.
     PubMed     Abstract available
     
     
     April 2018
156. TOPKAN E, Selek U, Ozdemir Y, Yildirim BA, et al
     Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2018 Apr 26. pii: S0360-3016(18)30720.
     PubMed     Abstract available
     
     
     
157. SHINTANI T, Matsuo Y, Iizuka Y, Mitsuyoshi T, et al
     A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
     Int J Radiat Oncol Biol Phys. 2018;100:1228-1236.
     PubMed     Abstract available
     
     
     
158. URBANIC JJ, McGarry RC, Daly ME, Palma DA, et al
     Locally Advanced Lung Cancer: Is It Time to Take Cardiac Protection Seriously in Radiation Planning?
     Int J Radiat Oncol Biol Phys. 2018;100:1091-1094.
     PubMed    
     
     
     
159. TRAN PT, Feng F, Ost P
     Live to SABR Another Day?
     Int J Radiat Oncol Biol Phys. 2018;100:1097.
     PubMed    
     
     
     March 2018
160. YEGYA-RAMAN N, Kim S, Deek MP, Li D, et al
     Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Mar 30. pii: S0360-3016(18)30557.
     PubMed     Abstract available
     
     
     
161. SCHAPIRA E, Hubbeling H, Yeap BY, Mehan WA Jr., et al
     Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2018 Mar 22. pii: S0360-3016(18)30542.
     PubMed     Abstract available
     
     
     
162. CHEN L, Douglass J, Kleinberg L, Ye X, et al
     Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2018;100:916-925.
     PubMed     Abstract available
     
     
     
163. ROACH MC, Robinson CG, Bradley JD
     Natural Disasters and the Importance of Minimizing Subsequent Radiation Therapy Interruptions for Locally Advanced Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;100:836-837.
     PubMed    
     
     
     
164. FRENZEL T, Siekmann J, Grohmann C, Valentiner U, et al
     Locally Ablative Radiation Therapy of a Primary Human Small Cell Lung Cancer Tumor Decreases the Number of Spontaneous Metastases in Two Xenograft Models.
     Int J Radiat Oncol Biol Phys. 2018;100:1044-1056.
     PubMed     Abstract available
     
     
     
165. HURMUZ P, Cengiz M, Zorlu F, Akyol F, et al
     In Regard to Kumar et al.
     Int J Radiat Oncol Biol Phys. 2018;100:1079-1080.
     PubMed    
     
     
     
166. NANTAVITHYA C, Gomez DR, Wei X, Komaki R, et al
     Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30316.
     PubMed     Abstract available
     
     
     
167. LEE SH, Rimner A, Gelb E, Deasy JO, et al
     Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30330.
     PubMed     Abstract available
     
     
     
168. BARNEY CL, Scoville N, Allan E, Ayan A, et al
     Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
     Int J Radiat Oncol Biol Phys. 2018;100:748-755.
     PubMed     Abstract available
     
     
     
169. MARQUEZ C
     Observe, and Keep Chemotherapy Up the Sleeve.
     Int J Radiat Oncol Biol Phys. 2018;100:550.
     PubMed    
     
     
     
170. LOURENCO LM, Jiang Y, Drobnitzky N, Green M, et al
     PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice.
     Int J Radiat Oncol Biol Phys. 2018;100:767-775.
     PubMed     Abstract available
     
     
     
171. TEKATLI H, Duijm M, Oomen-de Hoop E, Verbakel W, et al
     Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
     Int J Radiat Oncol Biol Phys. 2018;100:738-747.
     PubMed     Abstract available
     
     
     February 2018
172. LIU C, Schild SE, Chang JY, Liao Z, et al
     Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Feb 14. pii: S0360-3016(18)30256.
     PubMed     Abstract available
     
     
     
173. VYFHUIS MAL, Burrows WM, Bhooshan N, Suntharalingam M, et al
     Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30250.
     PubMed     Abstract available
     
     
     
174. HAQUE W, Verma V, Fakhreddine M, Butler EB, et al
     Trends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;100:470-477.
     PubMed     Abstract available
     
     
     
175. STEPHANS KL, Woody NM, Reddy CA, Varley M, et al
     Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;100:462-469.
     PubMed     Abstract available
     
     
     January 2018
176. URBANIC JJ, Wang X, Bogart JA, Stinchcombe TE, et al
     Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).
     Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30109.
     PubMed     Abstract available
     
     
     
177. LEE J, Li B, Cui Y, Sun X, et al
     A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Jan 10. pii: S0360-3016(18)30006.
     PubMed     Abstract available
     
     
     
178. POULSEN PR, Eley J, Langner U, Simone CB 2nd, et al
     Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle.
     Int J Radiat Oncol Biol Phys. 2018;100:226-234.
     PubMed     Abstract available
     
     
     
179. ITO K, Shimizuguchi T, Nihei K, Furuya T, et al
     Patterns of Intraosseous Recurrence After Stereotactic Body Radiation Therapy for Coxal Bone Metastasis.
     Int J Radiat Oncol Biol Phys. 2018;100:159-161.
     PubMed     Abstract available
     
     
     December 2017
180. BERNARD V, Bishop AJ, Allen PK, Amini B, et al
     Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
     Int J Radiat Oncol Biol Phys. 2017;99:1207-1215.
     PubMed     Abstract available
     
     
     
181. KELLER A, Dore M, Cebula H, Thillays F, et al
     Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
     Int J Radiat Oncol Biol Phys. 2017;99:1179-1189.
     PubMed     Abstract available
     
     
     November 2017
182. EVERITT S, Ball D, Hicks RJ, Callahan J, et al
     Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survi
     Int J Radiat Oncol Biol Phys. 2017;99:947-955.
     PubMed     Abstract available
     
     
     
183. NIEDZIELSKI JS, Yang J, Mohan R, Titt U, et al
     Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
     Int J Radiat Oncol Biol Phys. 2017;99:1013-1020.
     PubMed     Abstract available
     
     
     
184. VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
     Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
     Int J Radiat Oncol Biol Phys. 2017;99:859-866.
     PubMed     Abstract available
     
     
     
185. YU W, Tang C, Hobbs BP, Li X, et al
     Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Nov 15. pii: S0360-3016(17)34061.
     PubMed     Abstract available
     
     
     
186. JETER MD, Gomez D, Nguyen QN, Komaki R, et al
     Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer:
     Int J Radiat Oncol Biol Phys. 2017 Nov 3. pii: S0360-3016(17)34055.
     PubMed     Abstract available
     
     
     
187. KUMAR S, Feddock J, Li X, Shearer AJ, et al
     Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:652-659.
     PubMed     Abstract available
     
     
     October 2017
188. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
     Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Oct 28. pii: S0360-3016(17)34039.
     PubMed     Abstract available
     
     
     
189. ZHOU R, Xu T, Nguyen QN, Liu Y, et al
     Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017 Oct 12. pii: S0360-3016(17)33964.
     PubMed     Abstract available
     
     
     
190. WIJSMAN R, Dankers FJWM, Troost EGC, Hoffmann AL, et al
     Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:434-441.
     PubMed     Abstract available
     
     
     
191. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
     Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
     Int J Radiat Oncol Biol Phys. 2017;99:459-467.
     PubMed     Abstract available
     
     
     
192. VOGEL J, Lin L, Litzky LA, Berman AT, et al
     Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
     Int J Radiat Oncol Biol Phys. 2017;99:427-433.
     PubMed     Abstract available
     
     
     
193. JOCHEMS A, Deist TM, El Naqa I, Kessler M, et al
     Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.
     Int J Radiat Oncol Biol Phys. 2017;99:344-352.
     PubMed     Abstract available
     
     
     
194. BAHIG H, Campeau MP, Lapointe A, Bedwani S, et al
     Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.
     Int J Radiat Oncol Biol Phys. 2017;99:334-343.
     PubMed     Abstract available
     
     
     
195. FAUGHT AM, Miyasaka Y, Kadoya N, Castillo R, et al
     Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:325-333.
     PubMed     Abstract available
     
     
     
196. MODIRI A, Sabouri P, Gu X, Timmerman R, et al
     Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:317-324.
     PubMed     Abstract available
     
     
     September 2017
197. ERIKSSON M, Haag P, Brzozowska B, Lipka M, et al
     Analysis of Chromatin Opening in Heterochromatic Non-Small cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment.
     Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33933.
     PubMed     Abstract available
     
     
     
198. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
     Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
     PubMed     Abstract available
     
     
     
199. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
     Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
     Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
     PubMed    
     
     
     
200. SUN Y, Hawkins PG, Bi N, Dess RT, et al
     Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33836.
     PubMed     Abstract available
     
     
     
201. PATRICE GI, Lester-Coll NH, Yu JB, Amdahl J, et al
     Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
     Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33838.
     PubMed     Abstract available
     
     
     
202. KARKI K, Saraiya S, Hugo GD, Mukhopadhyay N, et al
     Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
     Int J Radiat Oncol Biol Phys. 2017;99:80-89.
     PubMed     Abstract available
     
     
     
203. NING MS, Tang L, Gomez DR, Xu T, et al
     Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:70-79.
     PubMed     Abstract available
     
     
     
204. VIVEKANANDAN S, Landau DB, Counsell N, Warren DR, et al
     The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:51-60.
     PubMed     Abstract available
     
     
     
205. DALY ME, Palma DA
     Prophylactic Cranial Irradiation for Small Cell Lung Cancer: New Insights.
     Int J Radiat Oncol Biol Phys. 2017;99:3-5.
     PubMed    
     
     
     
206. CHOI CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, et al
     Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
     Int J Radiat Oncol Biol Phys. 2017;99:16-21.
     PubMed     Abstract available
     
     
     
207. FAUGHT AM, Yamamoto T, Castillo R, Castillo E, et al
     Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:202-209.
     PubMed     Abstract available
     
     
     August 2017
208. GORGISYAN J, Munck Af Rosenschold P, Perrin R, Persson GF, et al
     Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33779.
     PubMed     Abstract available
     
     
     
209. CHURILLA TM, Ballman KV, Brown PD, Twohy EL, et al
     Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
     Int J Radiat Oncol Biol Phys. 2017 Aug 5. pii: S0360-3016(17)33691.
     PubMed     Abstract available
     
     
     
210. MCMILLAN MT, Ojerholm E, Verma V, Higgins KA, et al
     Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:1142-1152.
     PubMed     Abstract available
     
     
     
211. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
     Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
     Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
     PubMed     Abstract available
     
     
     
212. KIM TH, Kim MH, Kim BJ, Park SI, et al
     Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
     PubMed     Abstract available
     
     
     July 2017
213. FANG P, He W, Gomez DR, Hoffman KE, et al
     Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
     Int J Radiat Oncol Biol Phys. 2017;98:748-757.
     PubMed     Abstract available
     
     
     
214. MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
     Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:843-849.
     PubMed     Abstract available
     
     
     
215. WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
     Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
     Int J Radiat Oncol Biol Phys. 2017;98:726-732.
     PubMed     Abstract available
     
     
     
216. JAN N, Guy C, Reshko LB, Hugo GD, et al
     Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:683-690.
     PubMed     Abstract available
     
     
     
217. CHEN H, Senan S, Nossent EJ, Boldt RG, et al
     Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
     Int J Radiat Oncol Biol Phys. 2017;98:622-631.
     PubMed     Abstract available
     
     
     
218. WANG S, Campbell J, Stenmark MH, Zhao J, et al
     Plasma Levels of IL-8 and TGF-beta1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
     Int J Radiat Oncol Biol Phys. 2017;98:615-621.
     PubMed     Abstract available
     
     
     
219. EZE C, Roengvoraphoj O, Manapov F
     Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:612-614.
     PubMed    
     
     
     
220. REDMOND KJ, Hales RK, Anderson-Keightly H, Zhou XC, et al
     Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:603-611.
     PubMed     Abstract available
     
     
     
221. PRESS RH, Boselli DM, Symanowski JT, Lankford SP, et al
     External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:632-638.
     PubMed     Abstract available
     
     
     
222. RIEBER J, Abbassi-Senger N, Adebahr S, Andratschke N, et al
     Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
     Int J Radiat Oncol Biol Phys. 2017;98:511-520.
     PubMed     Abstract available
     
     
     June 2017
223. PAUL J, Yang C, Wu H, Tai A, et al
     Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2017;98:463-472.
     PubMed     Abstract available
     
     
     
224. HELOU J, Thibault I, Poon I, Chiang A, et al
     Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
     Int J Radiat Oncol Biol Phys. 2017;98:419-427.
     PubMed     Abstract available
     
     
     
225. BASCH E, Pugh SL, Dueck AC, Mitchell SA, et al
     Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
     Int J Radiat Oncol Biol Phys. 2017;98:409-418.
     PubMed     Abstract available
     
     
     
226. BANG A, Wilhite TJ, Pike LRG, Cagney DN, et al
     Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:344-351.
     PubMed     Abstract available
     
     
     May 2017
227. YAN SX, Qureshi MM, Truong MT, Mak KS, et al
     Patterns of Care and Survival Outcomes in Stage II Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database.
     Int J Radiat Oncol Biol Phys. 2017;98:251.
     PubMed    
     
     
     
228. DEVITT M, Hall R, Gentzler RD
     Peripheral Blood Cell Free DNA to Monitor Mutational Response in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:250.
     PubMed    
     
     
     
229. FAVE X, Zhang L, Yang J, Mackin D, et al
     Using Pretreatment Radiomics and Delta-Radiomics Features to Predict Non-Small Cell Lung Cancer Patient Outcomes.
     Int J Radiat Oncol Biol Phys. 2017;98:249.
     PubMed    
     
     
     
230. LAN M, Xu T, Gomez DR, Jeter MD, et al
     Association Between LGALS3 Gene Polymorphisms and Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:249-250.
     PubMed    
     
     
     
231. GUTTMANN DM, Doucette A, Gabriel PE, Morrissette JJD, et al
     Patterns of Failure in Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Implications for the Role of Definitive Local Therapy to the Primary Tumor.
     Int J Radiat Oncol Biol Phys. 2017;98:248-249.
     PubMed    
     
     
     
232. AHERNE N, Tune D, Ross A, Dwyer P, et al
     Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung Carcinoma.
     Int J Radiat Oncol Biol Phys. 2017;98:248.
     PubMed    
     
     
     
233. NI L, Koshy M, Connell PP, Hubert G, et al
     Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:247.
     PubMed    
     
     
     
234. SONI PD, Boonstra PS, Schipper M, Bazzi L, et al
     Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:247-248.
     PubMed    
     
     
     
235. CHEN H, Senan S, Nossent EJ, Boldt G, et al
     Treatment-Related Toxicity in Patients with Early Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review.
     Int J Radiat Oncol Biol Phys. 2017;98:245-246.
     PubMed    
     
     
     
236. XU T, Xu Y, Huo J, Yang P, et al
     Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:245.
     PubMed    
     
     
     
237. ZENG H, Li R, Hu C, Meng X, et al
     Hyperfractionated Accelerated Radiation Therapy May Increase Risk for Brain Metastases in Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:244.
     PubMed    
     
     
     
238. WEN Q, Meng X, Sun X, Hu M, et al
     Evaluation of Clinical and Demographic Factors Associated with Platinum-Sensitivity Status and Survival in Limited-Stage Small Cell Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:243.
     PubMed    
     
     
     
239. ROUNTREE CA, Zahra A, Russo JK, O'Keefe J, et al
     Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:243-244.
     PubMed    
     
     
     
240. ERKMEN C, Mitchell M
     Lung Cancer Screening in a Predominantly African-American Population.
     Int J Radiat Oncol Biol Phys. 2017;98:242-243.
     PubMed    
     
     
     
241. SHIN J, Russo GA
     Survival is Increasing for Patients with Stage I Non-Small Cell Lung Cancer Treated With Primary Radiation Therapy: We are Making Progress in the Era of Stereotactic Body Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:241.
     PubMed    
     
     
     
242. GOLDEN S, Thomas CR Jr, Slatore C
     It Wasn't as Bad as I Thought It Would Be: A Prospective, Qualitative Longitudinal Study of Early Stage Non-Small Cell Lung Cancer Patients After Treatment.
     Int J Radiat Oncol Biol Phys. 2017;98:241-242.
     PubMed    
     
     
     
243. JIN CJ, Kong W, MacKillop W
     Estimating the Need for Palliative Radiation Therapy for Lung Cancer: A Benchmarking Approach.
     Int J Radiat Oncol Biol Phys. 2017;98:240-241.
     PubMed    
     
     
     
244. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
     Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:239.
     PubMed    
     
     
     
245. G L, Agarwal V, Swamy K, Bhattacharjee S, et al
     Stereotactic Robotic Radiosurgery for 1-3 Brain Metastases from Non-Small Cell Lung Cancer: A Single Institutional Experience from South India.
     Int J Radiat Oncol Biol Phys. 2017;98:238.
     PubMed    
     
     
     
246. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
     Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:238-239.
     PubMed    
     
     
     
247. NGUYEN QN, Lu Y, Tang C, Chance WW, et al
     Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies?
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed    
     
     
     
248. MO X
     Low Expression of 12 DNA Repair Genes was Associated With Better Disease-free Survival in Non-Small Cell Lung Cancer Patients Having Adjuvant Chemotherapy.
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed    
     
     
     
249. YANG F, Chen L, Cheung W
     Attrition in the Treatment of Metastatic Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed    
     
     
     
250. HORNE ZD, Richman A, Clump DA 2nd, Burton SA, et al
     Mediastinal/Hilar Stereotactic Ablative Radiation Therapy for Primary and Oligorecurrent Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:237-238.
     PubMed    
     
     
     
251. GENTZLER RD, Mohindra NA, Hanna N, Chae YK, et al
     Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results.
     Int J Radiat Oncol Biol Phys. 2017;98:236.
     PubMed    
     
     
     
252. WEN Q, Meng X, Yue J, Ma C, et al
     Prediction of Early Response to Chemoradiation Therapy in Non-Small Cell Lung Cancer by Using Cone Beam Computed Tomography-Based Tumor Volume and Density Changes.
     Int J Radiat Oncol Biol Phys. 2017;98:235.
     PubMed    
     
     
     
253. ALJUMAILY R, Pleat N, George S, John S, et al
     A Histologic Guide in Treating Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:235.
     PubMed    
     
     
     
254. ACKERSON B, Boyle JM, Gu L, Kelsey CR, et al
     A Formal Assessment of the Dosimetric Advantages of Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:234.
     PubMed    
     
     
     
255. YANG P, Liao Z, Gomez DR, Xu T, et al
     Prospective Study of Marginal Recurrence in Patients with Non-Small Cell Lung Cancer After Proton or Photon Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:234.
     PubMed    
     
     
     
256. LIU J, Li C, Hu M, Lu J, et al
     Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer PET/CT Imaging Using 18F-FDG and 18F-FLT in Non-Small Cell Lung Cancer Patients: A Prospective Pilot Study.
     Int J Radiat Oncol Biol Phys. 2017;98:233.
     PubMed    
     
     
     
257. TAKEHANA K, Inokuchi H, Tsutsui K, Hiraoka M, et al
     Comparison of Radiation Dose of Induction Chemoradiation Therapy Followed by Surgery for Potentially Resectable Stage III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:233-234.
     PubMed    
     
     
     
258. NO H, Kikut J, Garrison G, Sidiropoulos N, et al
     Active Surveillance for Elderly Stage IA Non-Small Cell Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:232.
     PubMed    
     
     
     
259. SINGH DP, Bergsma DP, Cummings MA, Hare MZ, et al
     Outcome with Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer Using 5 Fractions: Single Institution Experience of 106 Consecutive Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:231-232.
     PubMed    
     
     
     
260. MANSUETI JR, Maillie S
     A Review of Non-Small Cell Lung Cancer Post-Treatment Follow-up Imaging Procedures with PET/CT Scans Versus CT Scans and the Effect on Patient Survival.
     Int J Radiat Oncol Biol Phys. 2017;98:231.
     PubMed    
     
     
     
261. POST CM, Verma V, Zhen W, Simone CB 2nd, et al
     Stereotactic Body Radiation Therapy for >/=5 cm Non-Small Cell Lung Cancer: Survey of United States Academic Thoracic Radiation Oncologists.
     Int J Radiat Oncol Biol Phys. 2017;98:230-231.
     PubMed    
     
     
     
262. BLUMENFELD PA, Kreinbrink PJ, Marwaha G
     Stereotactic Body Radiation Therapy Outcomes for Early Stage and Oligometastatic Non-Small Cell Lung Cancer Based on Molecular Profile.
     Int J Radiat Oncol Biol Phys. 2017;98:230.
     PubMed    
     
     
     
263. PEZZI TA, Mohamed ASR, Fuller CD, Blanchard P, et al
     Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non-Small Cell Lung cancer: An Analysis of the National Cancer Data Base.
     Int J Radiat Oncol Biol Phys. 2017;98:230.
     PubMed    
     
     
     
264. CASSIDY RJ 3RD, Patel PR, Zhang X, Press RH, et al
     Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:229-230.
     PubMed    
     
     
     
265. QIN A, Street L, Viglianti BL, Cease K, et al
     Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:228.
     PubMed    
     
     
     
266. NAGASAKA M, Sukari A
     Non-Small Cell Lung Cancer: Does Histology Matter?
     Int J Radiat Oncol Biol Phys. 2017;98:227-228.
     PubMed    
     
     
     
267. GAO Z, Meng X, Chen X, Sun X, et al
     Comparison of Tumor Volumes as Determined by Pathologic Examination and FLT-PET/CT Images of Non-Small Cell Lung Cancer: A Pilot Study.
     Int J Radiat Oncol Biol Phys. 2017;98:226-227.
     PubMed    
     
     
     
268. RAY M, Faris N, Rugless F, Smeltzer M, et al
     Multidisciplinary Care and the Use of Treatment Modalities for Non-Small Cell Lung Cancer (NSCLC) in a Large Community Healthcare Setting.
     Int J Radiat Oncol Biol Phys. 2017;98:226.
     PubMed    
     
     
     
269. ZHU HJ, Nichols RC Jr, Henderson RH, Morris CG, et al
     Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non-Small Cell Lung Cancer Patients Treated with Proton Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:225.
     PubMed    
     
     
     
270. GEBHARDT BJ, Horne ZD, Heron DE, Beriwal S, et al
     Standardization of Radiation Therapy Dose for Locally Advanced Non-Small Cell Lung Cancer Through Changes to a Lung Cancer Clinical Pathway in a Large, Integrated Comprehensive CancerCenter Network.
     Int J Radiat Oncol Biol Phys. 2017;98:225.
     PubMed    
     
     
     
271. SHARMA S, McMillan M, Doucette A, Cohen R, et al
     Impact of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small Cell Lung Cancer: A Propensity Score Matched Analysis of Patients in the National Cancer Database.
     Int J Radiat Oncol Biol Phys. 2017;98:224-225.
     PubMed    
     
     
     
272. AHMED KA, Grass GD, Creelan B, Gray J, et al
     Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:224.
     PubMed    
     
     
     
273. GAO S, Kim A, Puchalski J, Bramley K, et al
     Indications for Invasive Mediastinal Staging in Patients with Early Non-Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2017;98:223.
     PubMed    
     
     
     
274. SEPESI B, Cuentes EP, Canales JR, Behrens C, et al
     Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:223.
     PubMed    
     
     
     
275. DALWADI SM, Lewis G, Butler EB, Teh BS, et al
     Racial Disparities in the Treatment and Outcome of Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:223-224.
     PubMed    
     
     
     
276. JOLLY S, Sun Y, Hawkins PG, Bi N, et al
     Individualizing Radiation Dose in Locally Advanced Non-Small Cell Lung Cancer Patients Using Pretreatment Serum MicroRNA Signatures.
     Int J Radiat Oncol Biol Phys. 2017;98:222.
     PubMed    
     
     
     
277. CHINNIAH C, Aguarin L, Cheng P, DeCesaris C, et al
     Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:221.
     PubMed    
     
     
     
278. SINGH AK, Suescun JAG, Stephans KL, Bogart JA, et al
     A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:221-222.
     PubMed    
     
     
     
279. EDELMAN MJ, Wang X, Hodgson L, Cheney RT, et al
     Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance).
     Int J Radiat Oncol Biol Phys. 2017;98:220-221.
     PubMed    
     
     
     
280. PIOTROWSKA Z, Stirling K, Heist R, Campo M, et al
     Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy.
     Int J Radiat Oncol Biol Phys. 2017;98:220.
     PubMed    
     
     
     
281. FARRIS M, McTyre ER, Cramer CK, Hughes R, et al
     Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
     Int J Radiat Oncol Biol Phys. 2017;98:131-141.
     PubMed     Abstract available
     
     
     
282. WANG CJ, Christie A, Lin MH, Jung M, et al
     Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:91-100.
     PubMed     Abstract available
     
     
     
283. CHEN WS, Townsend JP, Yu JB
     Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets.
     Int J Radiat Oncol Biol Phys. 2017;98:8-10.
     PubMed    
     
     
     March 2017
284. GUCKENBERGER M
     SBRT in eight fractions.
     Int J Radiat Oncol Biol Phys. 2017;97:653.
     PubMed    
     
     
     
285. PALMA DA
     An Ultracentral Lung Tumor.
     Int J Radiat Oncol Biol Phys. 2017;97:651.
     PubMed    
     
     
     
286. MELOTEK JM, Chmura SJ
     Oligometastasis-Directed Ablative Therapy: A Clinical Trial Question.
     Int J Radiat Oncol Biol Phys. 2017;97:448.
     PubMed    
     
     
     February 2017
287. MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
     Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
     Int J Radiat Oncol Biol Phys. 2017;97:228-235.
     PubMed     Abstract available
     
     
     
288. GOMEZ D
     Induction Chemotherapy with Surgery and Post-operative Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;97:214.
     PubMed    
     
     
     
289. PALMA DA
     Plural Pleural Problems.
     Int J Radiat Oncol Biol Phys. 2017;97:213.
     PubMed    
     
     
     January 2017
290. KANEHIRA T, Matsuura T, Takao S, Matsuzaki Y, et al
     Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study.
     Int J Radiat Oncol Biol Phys. 2017;97:173-181.
     PubMed     Abstract available
     
     
     
291. LEEMAN JE, Rimner A, Montecalvo J, Hsu M, et al
     Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;97:138-145.
     PubMed     Abstract available
     
     
     December 2016
292. VANDERWALDE NA, Deal AM, Comitz E, Stravers L, et al
     Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016 Dec 2. pii: S0360-3016(16)33507.
     PubMed     Abstract available
     
     
     October 2016
293. SPERDUTO PW, Yang TJ, Beal K, Pan H, et al
     The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2016;96:406-13.
     PubMed     Abstract available
     
     
     September 2016
294. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
     Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
     Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: